Drupal.behaviors.print = function(context) {window.print();window.close();}>
Q&A: Matt Posard on Illumina's Clinically Focused Business Unit
March 14, 2012
Q&A: Matt Posard on Illumina's Clinically Focused Business Unit
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Transgenomic Launches NGS-Based Mitochondrial Disease Test, Developing Autism Risk Test
June 21, 2011 / Clinical Sequencing News
Analyst Says Sequencing-Based Dx Could Be 'Ultimate Opportunity' for Illumina
June 8, 2011 / Clinical Sequencing News
NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News
Analysts Increase Valuations, Upgrade Illumina
January 4, 2013 / GenomeWeb Daily News
Oxford Group Launches PGM-Based Cancer Test under UK's Stratified Medicine Program
January 2, 2013 / Clinical Sequencing News